Key result
Mavacamten reduces myosin in the DRX state by ~92% in porcine cardiac myofibrils.
Why the study?
Existing methods lack a way to preserve sarcomeric architecture while enabling rapid reagent exchange to quantify the cardiac reserve between complex single-molecule imaging and traditional stopped-flow bulk assays.
A novel fluorescence imaging approach using Cy3-ATP in porcine myofibrils demonstrates that mavacamten increases the super-relaxed myosin state, consistent with its clinical mechanism of action.
Answers are grounded in this paper and cite their sources.
Supports mechanistic consistency in porcine tissue; leaves open human translation and clinical relevance.
Cardiac muscle adapts to varying physiological demands by modulating the number of active myosin II motors available for contraction. These motors are organized into thick filaments in the sarcomere and generate force through an ATP-dependent interaction with thin filaments that contain actin. To conserve energy, when demand is low myosin can occupy the super-relaxed (SRX) state, which acts as a reserve. Here, we build upon the earlier studies to quantify the size of this cardiac reserve using fluorescence imaging of Cy3-ATP directly in myofibrils. This approach employs a pulse-chase method and exploits the high permeability of isolated myofibrils to monitor nucleotide release in situ. By preserving sarcomeric architecture while enabling rapid reagent exchange, this method bridges the gap between complex single-molecule imaging and traditional stopped-flow bulk assays using MANT-ATP. Using this approach we have studied biochemical perturbation of the SRX reserve with deoxyATP and mavacamten. DeoxyATP caused large depletion of the cardiac reserve, and mavacamten increased its size, consistent with its clinical application. Our results demonstrate the utility of this technique and the potential for further enhancement using multiplexing (i.e. imaging multiple samples in the same acquisition period), holding promise for future applications in health and disease.
No takes yet. Share an insight, caveat, or question.
Pilagov et al. (2025) studied Cardiac muscle physiology. Mavacamten vs. Untreated was evaluated on Percentage of myosin in the disordered-relaxed (DRX) state (p=<0.002). Mavacamten significantly reduced the proportion of myosin in the disordered-relaxed (DRX) state from 68.0% to 5.2% (p<0.002) in porcine cardiac myofibrils.
Synapse has enriched 10 related papers. Consider them for comparative context: